Search Results for: Schizophrenia

1632 interactions found:

Symbols Name 1 Name 2
Pathways 1
Pathways 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
CDK1 and KIF26B cyclin-dependent kinase 1 kinesin family member 26B
  • Phosphorylation of the APC/C
  • Signaling by FGFR in disease
  • Phosphorylation of Emi1
  • Signaling by EGFRvIII in Cancer
  • Toll Like Receptor TLR1:TLR2 Cascade
  • Toll Like Receptor 5 (TLR5) Cascade
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • MyD88 dependent cascade initiated on endosome
  • SOS-mediated signalling
  • Mitotic G1-G1/S phases
  • SHC-mediated signalling
  • Recruitment of mitotic centrosome proteins and complexes
  • TRIF-mediated TLR3/TLR4 signaling
  • ERK1 activation
  • Nuclear Pore Complex (NPC) Disassembly
  • APC/C:Cdc20 mediated degradation of mitotic proteins
  • Regulation of APC/C activators between G1/S and early anaphase
  • ERK1 activation
  • APC/C:Cdc20 mediated degradation of Cyclin B
  • Signaling by VEGF
  • Resolution of Sister Chromatid Cohesion
  • Downstream signal transduction
  • Signalling to RAS
  • Toll Like Receptor 3 (TLR3) Cascade
  • Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins
  • APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint
  • Interleukin-2 signaling
  • Mitotic G2-G2/M phases
  • Frs2-mediated activation
  • MASTL Facilitates Mitotic Progression
  • Axon guidance
  • IRS-mediated signalling
  • G2/M Transition
  • VEGFA-VEGFR2 Pathway
  • Activated TLR4 signalling
  • VEGFR2 mediated cell proliferation
  • GRB2 events in ERBB2 signaling
  • Cyclin A/B1 associated events during G2/M transition
  • Loss of Nlp from mitotic centrosomes
  • MyD88:Mal cascade initiated on plasma membrane
  • TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
  • NCAM signaling for neurite out-growth
  • RAF/MAP kinase cascade
  • Signalling to p38 via RIT and RIN
  • Innate Immune System
  • Condensation of Prometaphase Chromosomes
  • Signaling by Insulin receptor
  • E2F mediated regulation of DNA replication
  • Insulin receptor signalling cascade
  • Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes
  • G0 and Early G1
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • IRS-related events
  • SHC-related events
  • Signaling by FGFR
  • ARMS-mediated activation
  • Toll-Like Receptors Cascades
  • Toll Like Receptor 10 (TLR10) Cascade
  • Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
  • E2F-enabled inhibition of pre-replication complex formation
  • Regulation of mitotic cell cycle
  • Cell Cycle Checkpoints
  • Signaling by GPCR
  • G2/M Checkpoints
  • Mitotic Prophase
  • Golgi Cisternae Pericentriolar Stack Reorganization
  • FCERI mediated MAPK activation
  • Regulation of PLK1 Activity at G2/M Transition
  • SHC1 events in ERBB2 signaling
  • Signaling by SCF-KIT
  • DAP12 signaling
  • G1/S Transition
  • G1/S-Specific Transcription
  • Toll Like Receptor 9 (TLR9) Cascade
  • G2/M DNA replication checkpoint
  • Signaling by PDGF
  • DAP12 interactions
  • SHC-related events triggered by IGF1R
  • GRB2 events in EGFR signaling
  • Signaling by ERBB4
  • APC/C-mediated degradation of cell cycle proteins
  • Toll Like Receptor 2 (TLR2) Cascade
  • Signaling by ERBB2
  • Signaling by EGFR
  • Signaling by Interleukins
  • SHC1 events in ERBB4 signaling
  • Toll Like Receptor 4 (TLR4) Cascade
  • Fc epsilon receptor (FCERI) signaling
  • Signaling by EGFR in Cancer
  • Condensation of Prophase Chromosomes
  • Signaling by Leptin
  • Signalling to ERKs
  • Mitotic Prometaphase
  • Prolonged ERK activation events
  • Organelle biogenesis and maintenance
  • ERK activation
  • Toll Like Receptor 7/8 (TLR7/8) Cascade
  • Activation of NIMA Kinases NEK9, NEK6, NEK7
  • Nuclear Envelope Breakdown
  • IGF1R signaling cascade
  • Recruitment of NuMA to mitotic centrosomes
  • Cyclin B2 mediated events
  • Toll Like Receptor TLR6:TLR2 Cascade
  • M Phase
  • IRS-related events triggered by IGF1R
  • MyD88 cascade initiated on plasma membrane
  • ERK activation
  • Downstream signaling of activated FGFR
  • Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex
  • Signalling by NGF
  • SOS-mediated signalling
  • G2/M DNA damage checkpoint
  • MAP kinase activation in TLR cascade
  • SHC-mediated signalling
  • Depolymerisation of the Nuclear Lamina
  • Assembly of the primary cilium
  • Cytokine Signaling in Immune system
  • NGF signalling via TRKA from the plasma membrane
  • Signaling by Overexpressed Wild-Type EGFR in Cancer
  • MyD88-independent cascade
  • Anchoring of the basal body to the plasma membrane
  • Cell Cycle, Mitotic
  • SHC1 events in EGFR signaling
  • Loss of proteins required for interphase microtubule organization from the centrosome
  • FRS2-mediated cascade
  • IRS-mediated signalling
  • Centrosome maturation
  • Indirubin-3\'-Monoxime
  • Olomoucine
  • Hymenialdisine
  • SU9516
  • Flavopiridol
  • Alsterpaullone
FGA and PRRC2A fibrinogen alpha chain proline-rich coiled-coil 2A
  • p130Cas linkage to MAPK signaling for integrins
  • Integrin alphaIIb beta3 signaling
  • Platelet degranulation
  • GRB2:SOS provides linkage to MAPK signaling for Integrins
  • Platelet Aggregation (Plug Formation)
  • Formation of Fibrin Clot (Clotting Cascade)
  • Common Pathway
  • Amyloids
  • Response to elevated platelet cytosolic Ca2+
  • Integrin cell surface interactions
  • Platelet activation, signaling and aggregation
  • Alteplase
  • Reteplase
  • Anistreplase
  • Tenecteplase
  • Sucralfate
  • Alpha-D-Mannose
FGF2 and NRP1 fibroblast growth factor 2 (basic) neuropilin 1
  • Signaling by the B Cell Receptor (BCR)
  • Phospholipase C-mediated cascade
  • Signaling by FGFR in disease
  • SHC-mediated cascade
  • Signaling by EGFRvIII in Cancer
  • Signaling by SCF-KIT
  • Signaling by FGFR2 mutants
  • Downstream signaling events of B Cell Receptor (BCR)
  • DAP12 signaling
  • PI3K/AKT activation
  • PI-3K cascade
  • Signaling by activated point mutants of FGFR1
  • Signaling by FGFR1 mutants
  • PI3K Cascade
  • Negative regulation of FGFR signaling
  • Signaling by PDGF
  • DAP12 interactions
  • GAB1 signalosome
  • Signaling by ERBB4
  • Role of LAT2/NTAL/LAB on calcium mobilization
  • Constitutive PI3K/AKT Signaling in Cancer
  • Activated point mutants of FGFR2
  • PI3K events in ERBB4 signaling
  • Signaling by ERBB2
  • FGFR4 ligand binding and activation
  • Syndecan interactions
  • Signaling by EGFR
  • Signaling by FGFR3 mutants
  • Downstream signal transduction
  • Signaling by activated point mutants of FGFR3
  • Fc epsilon receptor (FCERI) signaling
  • Signaling by FGFR mutants
  • Signaling by EGFR in Cancer
  • PI3K/AKT Signaling in Cancer
  • Adaptive Immune System
  • IRS-mediated signalling
  • PIP3 activates AKT signaling
  • IGF1R signaling cascade
  • IRS-related events triggered by IGF1R
  • Transcriptional regulation of pluripotent stem cells
  • PI3K events in ERBB2 signaling
  • FGFR1b ligand binding and activation
  • Downstream signaling of activated FGFR
  • FGFR3c ligand binding and activation
  • FGFR1c ligand binding and activation
  • FGFR2c ligand binding and activation
  • FGFR ligand binding and activation
  • POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation
  • Signaling by Insulin receptor
  • Innate Immune System
  • Signalling by NGF
  • Insulin receptor signalling cascade
  • IRS-related events
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • NGF signalling via TRKA from the plasma membrane
  • Non-integrin membrane-ECM interactions
  • FGFR3 ligand binding and activation
  • Signaling by Overexpressed Wild-Type EGFR in Cancer
  • Signaling by FGFR
  • FGFR2 ligand binding and activation
  • FRS2-mediated cascade
  • IRS-mediated signalling
  • FGFR1 ligand binding and activation
  • Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
  • PI3K Cascade
  • Signal transduction by L1
  • CHL1 interactions
  • Axon guidance
  • Semaphorin interactions
  • Signaling by VEGF
  • Sema3A PAK dependent Axon repulsion
  • Neurophilin interactions with VEGF and VEGFR
  • L1CAM interactions
  • SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion
  • CRMPs in Sema3A signaling
  • Sucralfate
  • Pentosan Polysulfate
  • Sirolimus
  • 1,4-Dideoxy-O2-Sulfo-Glucuronic Acid
  • N,O6-Disulfo-Glucosamine
  • 1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid
FLT1 and NRP1 fms-related tyrosine kinase 1 neuropilin 1
  • VEGF binds to VEGFR leading to receptor dimerization
  • VEGF ligand-receptor interactions
  • Signaling by VEGF
  • Neurophilin interactions with VEGF and VEGFR
  • Signal transduction by L1
  • CHL1 interactions
  • Axon guidance
  • Semaphorin interactions
  • Signaling by VEGF
  • Sema3A PAK dependent Axon repulsion
  • Neurophilin interactions with VEGF and VEGFR
  • L1CAM interactions
  • SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion
  • CRMPs in Sema3A signaling
  • Sorafenib
  • Sunitinib
  • Pazopanib
  • Axitinib
  • N-(4-chlorophenyl)-2-[(pyridin-4-ylmethyl)amino]benzamide
  • Regorafenib
GLUD1 and LSM1 glutamate dehydrogenase 1 LSM1, U6 small nuclear RNA associated
  • Amino acid synthesis and interconversion (transamination)
  • Metabolism of amino acids and derivatives
  • mRNA decay by 5' to 3' exoribonuclease
  • Deadenylation-dependent mRNA decay
  • L-Glutamic Acid
  • NADH
  • Hexachlorophene
  • Nicotinamide-Adenine-Dinucleotide
  • Adenosine-5\'-Diphosphate
  • Guanosine-5\'-Triphosphate
SYK and HDAC4 spleen tyrosine kinase histone deacetylase 4
  • Signaling by the B Cell Receptor (BCR)
  • FCERI mediated MAPK activation
  • Platelet Aggregation (Plug Formation)
  • DAP12 signaling
  • Regulation of signaling by CBL
  • Role of phospholipids in phagocytosis
  • Fcgamma receptor (FCGR) dependent phagocytosis
  • FCGR activation
  • Regulation of actin dynamics for phagocytic cup formation
  • Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
  • Innate Immune System
  • DAP12 interactions
  • Integrin alphaIIb beta3 signaling
  • Cytokine Signaling in Immune system
  • Role of LAT2/NTAL/LAB on calcium mobilization
  • Signaling by Interleukins
  • Fc epsilon receptor (FCERI) signaling
  • GPVI-mediated activation cascade
  • Interleukin-2 signaling
  • FCERI mediated Ca+2 mobilization
  • Platelet activation, signaling and aggregation
  • Interleukin-3, 5 and GM-CSF signaling
  • Adaptive Immune System
  • Signaling by NOTCH1 HD Domain Mutants in Cancer
  • Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
  • Signaling by NOTCH
  • Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant
  • NOTCH1 Intracellular Domain Regulates Transcription
  • Signaling by NOTCH1
  • Signaling by NOTCH1 PEST Domain Mutants in Cancer
  • Signaling by NOTCH1 in Cancer
  • Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
  • Constitutive Signaling by NOTCH1 PEST Domain Mutants
  • FBXW7 Mutants and NOTCH1 in Cancer
  • Staurosporine
  • N-(2-hydroxy-1,1-dimethylethyl)-1-methyl-3-(1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-indole-5-carboxamide
  • 6-({5-fluoro-2-[(3,4,5-trimethoxyphenyl)amino]pyrimidin-4-yl}amino)-2,2-dimethyl-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one
  • 2-{2-[(3,5-dimethylphenyl)amino]pyrimidin-4-yl}-N-[(1S)-2-hydroxy-1-methylethyl]-4-methyl-1,3-thiazole-5-carboxamide
  • 2-{[(1R,2S)-2-aminocyclohexyl]amino}-4-[(3-methylphenyl)amino]pyrimidine-5-carboxamide
  • Ellagic Acid
GAPDH and ANXA1 glyceraldehyde-3-phosphate dehydrogenase annexin A1
  • Gluconeogenesis
  • Glucose metabolism
  • Myoclonic epilepsy of Lafora
  • Glycogen storage diseases
  • Glycolysis
  • Metabolism of carbohydrates
  • G alpha (q) signalling events
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • Signaling by GPCR
  • Class A/1 (Rhodopsin-like receptors)
  • GPCR ligand binding
  • Metabolic disorders of biological oxidation enzymes
  • Formyl peptide receptors bind formyl peptides and many other ligands
  • G alpha (q) signalling events
  • GPCR downstream signaling
  • Peptide ligand-binding receptors
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • G alpha (i) signalling events
  • NADH
  • Nicotinamide-Adenine-Dinucleotide
  • Adenosine-5-Diphosphoribose
  • Thionicotinamide-Adenine-Dinucleotide
  • 4-(2-AMINOETHYL)BENZENESULFONYL FLUORIDE
  • Amcinonide
  • Hydrocortisone
  • Dexamethasone
ELANE and CXCL12 elastase, neutrophil expressed chemokine (C-X-C motif) ligand 12
  • Collagen degradation
  • Activation of Matrix Metalloproteinases
  • Degradation of the extracellular matrix
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • Signaling by GPCR
  • Class A/1 (Rhodopsin-like receptors)
  • Signaling by ERBB4
  • GPCR ligand binding
  • Metabolic disorders of biological oxidation enzymes
  • GPCR downstream signaling
  • Nuclear signaling by ERBB4
  • Peptide ligand-binding receptors
  • Chemokine receptors bind chemokines
  • G alpha (i) signalling events
  • Pegfilgrastim
  • Alpha-1-proteinase inhibitor
  • Filgrastim
  • Mdl 101,146
  • ONO-6818
  • Tinzaparin
ERBB2 and ANKS1B erb-b2 receptor tyrosine kinase 2 ankyrin repeat and sterile alpha motif domain containing 1B
  • Signaling by the B Cell Receptor (BCR)
  • Signaling by FGFR in disease
  • Axon guidance
  • PIP3 activates AKT signaling
  • GRB7 events in ERBB2 signaling
  • Signaling by EGFRvIII in Cancer
  • PLCG1 events in ERBB2 signaling
  • Signaling by SCF-KIT
  • SHC1 events in ERBB2 signaling
  • Downstream signaling events of B Cell Receptor (BCR)
  • DAP12 signaling
  • PI3K/AKT activation
  • PI-3K cascade
  • GRB2 events in ERBB2 signaling
  • PI3K events in ERBB2 signaling
  • Downstream signaling of activated FGFR
  • Sema4D in semaphorin signaling
  • Sema4D induced cell migration and growth-cone collapse
  • Innate Immune System
  • Signaling by PDGF
  • Downregulation of ERBB2:ERBB3 signaling
  • Signalling by NGF
  • DAP12 interactions
  • GAB1 signalosome
  • Semaphorin interactions
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • NGF signalling via TRKA from the plasma membrane
  • Signaling by ERBB4
  • Signaling by Overexpressed Wild-Type EGFR in Cancer
  • Role of LAT2/NTAL/LAB on calcium mobilization
  • Constitutive PI3K/AKT Signaling in Cancer
  • PI3K events in ERBB4 signaling
  • Signaling by FGFR
  • Signaling by ERBB2
  • Signaling by EGFR
  • Downstream signal transduction
  • Fc epsilon receptor (FCERI) signaling
  • Signaling by EGFR in Cancer
  • PI3K/AKT Signaling in Cancer
  • Adaptive Immune System
  • Trastuzumab
  • Lapatinib
  • ado-trastuzumab emtansine
  • Pertuzumab
  • Afatinib
ERBB2 and RIN2 erb-b2 receptor tyrosine kinase 2 Ras and Rab interactor 2
  • Signaling by the B Cell Receptor (BCR)
  • Signaling by FGFR in disease
  • Axon guidance
  • PIP3 activates AKT signaling
  • GRB7 events in ERBB2 signaling
  • Signaling by EGFRvIII in Cancer
  • PLCG1 events in ERBB2 signaling
  • Signaling by SCF-KIT
  • SHC1 events in ERBB2 signaling
  • Downstream signaling events of B Cell Receptor (BCR)
  • DAP12 signaling
  • PI3K/AKT activation
  • PI-3K cascade
  • GRB2 events in ERBB2 signaling
  • PI3K events in ERBB2 signaling
  • Downstream signaling of activated FGFR
  • Sema4D in semaphorin signaling
  • Sema4D induced cell migration and growth-cone collapse
  • Innate Immune System
  • Signaling by PDGF
  • Downregulation of ERBB2:ERBB3 signaling
  • Signalling by NGF
  • DAP12 interactions
  • GAB1 signalosome
  • Semaphorin interactions
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • NGF signalling via TRKA from the plasma membrane
  • Signaling by ERBB4
  • Signaling by Overexpressed Wild-Type EGFR in Cancer
  • Role of LAT2/NTAL/LAB on calcium mobilization
  • Constitutive PI3K/AKT Signaling in Cancer
  • PI3K events in ERBB4 signaling
  • Signaling by FGFR
  • Signaling by ERBB2
  • Signaling by EGFR
  • Downstream signal transduction
  • Fc epsilon receptor (FCERI) signaling
  • Signaling by EGFR in Cancer
  • PI3K/AKT Signaling in Cancer
  • Adaptive Immune System
  • Trastuzumab
  • Lapatinib
  • ado-trastuzumab emtansine
  • Pertuzumab
  • Afatinib
PPIA and TCF4 peptidylprolyl isomerase A (cyclophilin A) transcription factor 4
  • HIV Infection
  • Host Interactions of HIV factors
  • Integration of provirus
  • Platelet degranulation
  • Basigin interactions
  • Late Phase of HIV Life Cycle
  • Cell surface interactions at the vascular wall
  • Uncoating of the HIV Virion
  • Early Phase of HIV Life Cycle
  • Reverse Transcription of HIV RNA
  • Assembly Of The HIV Virion
  • HIV Life Cycle
  • Budding and maturation of HIV virion
  • Response to elevated platelet cytosolic Ca2+
  • Minus-strand DNA synthesis
  • Platelet activation, signaling and aggregation
  • Binding and entry of HIV virion
  • Plus-strand DNA synthesis
  • APOBEC3G mediated resistance to HIV-1 infection
  • CDO in myogenesis
  • Myogenesis
  • Cyclosporine
  • L-Proline
  • (3r)-1-Acetyl-3-Methylpiperidine
  • Ethyl Oxo(Piperidin-1-Yl)Acetate
  • (3s,6s,9r,10r,11s,12s,13e,15e,18s,21s)-18-{(1e,3e,7s,8s)-9-[(2s,3r,4s,5s,6r,9s,11s)-9-Ethyl-4-Hydroxy-3,5,11-Trimethyl-8-Oxo-1-Oxa-7-Azaspiro[5.5]Undec-2-Yl]-8-Hydroxy-1,7-Dimethylnona-1,3-Dienyl}-10,12-Dihydroxy-3-(3-Hydroxybenzyl)-6-Isopropyl-11-Methyl-
IKBKB and NFKB1 inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
  • Signaling by the B Cell Receptor (BCR)
  • NF-kB is activated and signals survival
  • RIP-mediated NFkB activation via ZBP1
  • IRAK1 recruits IKK complex
  • Downstream signaling events of B Cell Receptor (BCR)
  • Toll Like Receptor TLR1:TLR2 Cascade
  • FCERI mediated NF-kB activation
  • Toll Like Receptor 5 (TLR5) Cascade
  • NOD1/2 Signaling Pathway
  • MyD88 dependent cascade initiated on endosome
  • Toll Like Receptor 9 (TLR9) Cascade
  • IRAK1 recruits IKK complex
  • TRIF-mediated TLR3/TLR4 signaling
  • Toll Like Receptor 2 (TLR2) Cascade
  • TCR signaling
  • Signaling by Interleukins
  • Toll Like Receptor 4 (TLR4) Cascade
  • Toll Like Receptor 3 (TLR3) Cascade
  • Fc epsilon receptor (FCERI) signaling
  • Interleukin-1 signaling
  • Adaptive Immune System
  • TAK1 activates NFkB by phosphorylation and activation of IKKs complex
  • Downstream TCR signaling
  • p75NTR recruits signalling complexes
  • Toll Like Receptor 7/8 (TLR7/8) Cascade
  • Toll Like Receptor TLR6:TLR2 Cascade
  • Activated TLR4 signalling
  • MyD88 cascade initiated on plasma membrane
  • ZBP1(DAI) mediated induction of type I IFNs
  • p75NTR signals via NF-kB
  • MyD88:Mal cascade initiated on plasma membrane
  • TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
  • Innate Immune System
  • Signalling by NGF
  • IKK complex recruitment mediated by RIP1
  • Cytosolic sensors of pathogen-associated DNA
  • p75 NTR receptor-mediated signalling
  • Cytokine Signaling in Immune system
  • MyD88-independent cascade
  • Toll-Like Receptors Cascades
  • RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
  • Toll Like Receptor 10 (TLR10) Cascade
  • Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways
  • Activation of NF-kappaB in B cells
  • TRAF6 mediated NF-kB activation
  • NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10
  • IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation
  • Signaling by the B Cell Receptor (BCR)
  • NF-kB is activated and signals survival
  • Downstream TCR signaling
  • Toll Like Receptor 7/8 (TLR7/8) Cascade
  • Cellular Senescence
  • RIP-mediated NFkB activation via ZBP1
  • Toll Like Receptor TLR6:TLR2 Cascade
  • DEx/H-box helicases activate type I IFN and inflammatory cytokines production
  • Activated TLR4 signalling
  • Toll Like Receptor TLR1:TLR2 Cascade
  • Downstream signaling events of B Cell Receptor (BCR)
  • FCERI mediated NF-kB activation
  • MyD88 cascade initiated on plasma membrane
  • Toll Like Receptor 5 (TLR5) Cascade
  • ZBP1(DAI) mediated induction of type I IFNs
  • p75NTR signals via NF-kB
  • Transcriptional regulation of white adipocyte differentiation
  • MyD88 dependent cascade initiated on endosome
  • TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
  • MyD88:Mal cascade initiated on plasma membrane
  • Toll Like Receptor 9 (TLR9) Cascade
  • Innate Immune System
  • Regulated proteolysis of p75NTR
  • Signalling by NGF
  • TRIF-mediated TLR3/TLR4 signaling
  • Cytosolic sensors of pathogen-associated DNA
  • Senescence-Associated Secretory Phenotype (SASP)
  • Cytokine Signaling in Immune system
  • p75 NTR receptor-mediated signalling
  • MyD88-independent cascade
  • Toll Like Receptor 2 (TLR2) Cascade
  • RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
  • Signaling by Interleukins
  • TCR signaling
  • Toll-Like Receptors Cascades
  • Toll Like Receptor 10 (TLR10) Cascade
  • Interleukin-1 processing
  • Toll Like Receptor 3 (TLR3) Cascade
  • Toll Like Receptor 4 (TLR4) Cascade
  • Activation of NF-kappaB in B cells
  • Fc epsilon receptor (FCERI) signaling
  • TRAF6 mediated NF-kB activation
  • Interleukin-1 signaling
  • Adaptive Immune System
  • TAK1 activates NFkB by phosphorylation and activation of IKKs complex
  • Mesalazine
  • Sulfasalazine
  • Auranofin
  • Arsenic trioxide
  • Thalidomide
  • Pranlukast
  • Triflusal
IL2RA and NFKB1 interleukin 2 receptor, alpha nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
  • Signaling by GPCR
  • G-protein beta:gamma signalling
  • Cytokine Signaling in Immune system
  • Signaling by Interleukins
  • GPCR downstream signaling
  • Interleukin receptor SHC signaling
  • G beta:gamma signalling through PI3Kgamma
  • Interleukin receptor SHC signaling
  • GPVI-mediated activation cascade
  • Interleukin-2 signaling
  • Platelet activation, signaling and aggregation
  • Interleukin-3, 5 and GM-CSF signaling
  • Signaling by the B Cell Receptor (BCR)
  • NF-kB is activated and signals survival
  • Downstream TCR signaling
  • Toll Like Receptor 7/8 (TLR7/8) Cascade
  • Cellular Senescence
  • RIP-mediated NFkB activation via ZBP1
  • Toll Like Receptor TLR6:TLR2 Cascade
  • DEx/H-box helicases activate type I IFN and inflammatory cytokines production
  • Activated TLR4 signalling
  • Toll Like Receptor TLR1:TLR2 Cascade
  • Downstream signaling events of B Cell Receptor (BCR)
  • FCERI mediated NF-kB activation
  • MyD88 cascade initiated on plasma membrane
  • Toll Like Receptor 5 (TLR5) Cascade
  • ZBP1(DAI) mediated induction of type I IFNs
  • p75NTR signals via NF-kB
  • Transcriptional regulation of white adipocyte differentiation
  • MyD88 dependent cascade initiated on endosome
  • TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
  • MyD88:Mal cascade initiated on plasma membrane
  • Toll Like Receptor 9 (TLR9) Cascade
  • Innate Immune System
  • Regulated proteolysis of p75NTR
  • Signalling by NGF
  • TRIF-mediated TLR3/TLR4 signaling
  • Cytosolic sensors of pathogen-associated DNA
  • Senescence-Associated Secretory Phenotype (SASP)
  • Cytokine Signaling in Immune system
  • p75 NTR receptor-mediated signalling
  • MyD88-independent cascade
  • Toll Like Receptor 2 (TLR2) Cascade
  • RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
  • Signaling by Interleukins
  • TCR signaling
  • Toll-Like Receptors Cascades
  • Toll Like Receptor 10 (TLR10) Cascade
  • Interleukin-1 processing
  • Toll Like Receptor 3 (TLR3) Cascade
  • Toll Like Receptor 4 (TLR4) Cascade
  • Activation of NF-kappaB in B cells
  • Fc epsilon receptor (FCERI) signaling
  • TRAF6 mediated NF-kB activation
  • Interleukin-1 signaling
  • Adaptive Immune System
  • TAK1 activates NFkB by phosphorylation and activation of IKKs complex
  • Denileukin diftitox
  • Aldesleukin
  • Basiliximab
  • Daclizumab
  • Thalidomide
  • Pranlukast
  • Triflusal
IKBKB and CSF2RA inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage)
  • Signaling by the B Cell Receptor (BCR)
  • NF-kB is activated and signals survival
  • RIP-mediated NFkB activation via ZBP1
  • IRAK1 recruits IKK complex
  • Downstream signaling events of B Cell Receptor (BCR)
  • Toll Like Receptor TLR1:TLR2 Cascade
  • FCERI mediated NF-kB activation
  • Toll Like Receptor 5 (TLR5) Cascade
  • NOD1/2 Signaling Pathway
  • MyD88 dependent cascade initiated on endosome
  • Toll Like Receptor 9 (TLR9) Cascade
  • IRAK1 recruits IKK complex
  • TRIF-mediated TLR3/TLR4 signaling
  • Toll Like Receptor 2 (TLR2) Cascade
  • TCR signaling
  • Signaling by Interleukins
  • Toll Like Receptor 4 (TLR4) Cascade
  • Toll Like Receptor 3 (TLR3) Cascade
  • Fc epsilon receptor (FCERI) signaling
  • Interleukin-1 signaling
  • Adaptive Immune System
  • TAK1 activates NFkB by phosphorylation and activation of IKKs complex
  • Downstream TCR signaling
  • p75NTR recruits signalling complexes
  • Toll Like Receptor 7/8 (TLR7/8) Cascade
  • Toll Like Receptor TLR6:TLR2 Cascade
  • Activated TLR4 signalling
  • MyD88 cascade initiated on plasma membrane
  • ZBP1(DAI) mediated induction of type I IFNs
  • p75NTR signals via NF-kB
  • MyD88:Mal cascade initiated on plasma membrane
  • TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
  • Innate Immune System
  • Signalling by NGF
  • IKK complex recruitment mediated by RIP1
  • Cytosolic sensors of pathogen-associated DNA
  • p75 NTR receptor-mediated signalling
  • Cytokine Signaling in Immune system
  • MyD88-independent cascade
  • Toll-Like Receptors Cascades
  • RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
  • Toll Like Receptor 10 (TLR10) Cascade
  • Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways
  • Activation of NF-kappaB in B cells
  • TRAF6 mediated NF-kB activation
  • NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10
  • IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation
  • Signaling by GPCR
  • G-protein beta:gamma signalling
  • Cytokine Signaling in Immune system
  • GPCR downstream signaling
  • Signaling by Interleukins
  • Interleukin receptor SHC signaling
  • G beta:gamma signalling through PI3Kgamma
  • Interleukin receptor SHC signaling
  • GPVI-mediated activation cascade
  • Interleukin-2 signaling
  • Platelet activation, signaling and aggregation
  • Interleukin-3, 5 and GM-CSF signaling
  • Mesalazine
  • Sulfasalazine
  • Auranofin
  • Arsenic trioxide
  • Sargramostim
PPP1CC and IL3RA protein phosphatase 1, catalytic subunit, gamma isozyme interleukin 3 receptor, alpha (low affinity)
  • Loss of Function of TGFBR2 in Cancer
  • Mitotic Prometaphase
  • Metabolism of lipids and lipoproteins
  • Separation of Sister Chromatids
  • Downregulation of TGF-beta receptor signaling
  • SMAD2/3 MH2 Domain Mutants in Cancer
  • TGF-beta receptor signaling activates SMADs
  • Mitotic Anaphase
  • TGFBR1 LBD Mutants in Cancer
  • M Phase
  • Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis
  • TGFBR2 MSI Frameshift Mutants in Cancer
  • SMAD2/3 Phosphorylation Motif Mutants in Cancer
  • Loss of Function of SMAD2/3 in Cancer
  • TGFBR2 Kinase Domain Mutants in Cancer
  • Loss of Function of SMAD4 in Cancer
  • TGFBR1 KD Mutants in Cancer
  • Lipid digestion, mobilization, and transport
  • Cell Cycle, Mitotic
  • Loss of Function of TGFBR1 in Cancer
  • Signaling by TGF-beta Receptor Complex in Cancer
  • Signaling by TGF-beta Receptor Complex
  • Resolution of Sister Chromatid Cohesion
  • Mitotic Metaphase and Anaphase
  • SMAD4 MH2 Domain Mutants in Cancer
  • Signaling by GPCR
  • G-protein beta:gamma signalling
  • Cytokine Signaling in Immune system
  • GPCR downstream signaling
  • Signaling by Interleukins
  • Interleukin receptor SHC signaling
  • G beta:gamma signalling through PI3Kgamma
  • Interleukin receptor SHC signaling
  • GPVI-mediated activation cascade
  • Interleukin-2 signaling
  • Platelet activation, signaling and aggregation
  • Interleukin-3, 5 and GM-CSF signaling
  • 9,10-Deepithio-9,10-Didehydroacanthifolicin
  • Calyculin A
  • (2S,5R,8S,11R,12S,15S,18S,19S,E)-8-ISOBUTYL-18-((5S,6S)-6-METHOXY-3,5-DIMETHYL-7-PHENYLHEPTYL)-1,2,5,12,15,19-HEXAMETHYL-3,6,9,13,16,20,25-HEPTAOXO-1,4,7,10,14,17,21-HEPTAAZACYCLOPENTACOS-21-ENE-11,22-DICARBOXYLIC ACID
  • Motuporin
  • Sargramostim
GLRA2 and BAG6 glycine receptor, alpha 2 BCL2-associated athanogene 6
  • Ion channel transport
  • Ligand-gated ion channel transport
  • Glycine
  • Lindane
  • Picrotoxin
  • Ethanol
GRIN2D and TRAF3 glutamate receptor, ionotropic, N-methyl D-aspartate 2D TNF receptor-associated factor 3
  • Activation of NMDA receptor upon glutamate binding and postsynaptic events
  • CREB phosphorylation through the activation of CaMKII
  • CREB phosphorylation through the activation of Ras
  • Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
  • Unblocking of NMDA receptor, glutamate binding and activation
  • Ras activation uopn Ca2+ infux through NMDA receptor
  • Post NMDA receptor activation events
  • Transmission across Chemical Synapses
  • Activated TLR4 signalling
  • RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
  • TRAF3-dependent IRF activation pathway
  • Toll-Like Receptors Cascades
  • Negative regulators of RIG-I/MDA5 signaling
  • TRIF-mediated TLR3/TLR4 signaling
  • Toll Like Receptor 4 (TLR4) Cascade
  • Toll Like Receptor 3 (TLR3) Cascade
  • MyD88-independent cascade
  • Innate Immune System
  • Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon
  • L-Glutamic Acid
  • Meperidine
  • Orphenadrine
  • Tenocyclidine
IL1B and IL1R2 interleukin 1, beta interleukin 1 receptor, type II
  • Signaling by Interleukins
  • Interleukin-1 processing
  • Interleukin-1 signaling
  • Cytokine Signaling in Immune system
  • Signaling by Interleukins
  • Cytokine Signaling in Immune system
  • Interleukin-1 signaling
  • Minocycline
  • Gallium nitrate
  • Canakinumab
  • Rilonacept
LRP2 and ANKS1B low density lipoprotein receptor-related protein 2 ankyrin repeat and sterile alpha motif domain containing 1B
  • Metabolism of lipids and lipoproteins
  • Visual phototransduction
  • Diseases associated with visual transduction
  • Metabolism of steroid hormones and vitamin D
  • Vitamin D (calciferol) metabolism
  • Retinoid metabolism and transport
  • Urokinase
  • Insulin Regular
  • Insulin, porcine
  • Gentamicin
PRKCA and NRGN protein kinase C, alpha neurogranin (protein kinase C substrate, RC3)
  • Ca-dependent events
  • Signaling by GPCR
  • CaM pathway
  • Signaling by FGFR in disease
  • Phospholipase C-mediated cascade
  • Integration of energy metabolism
  • Mitotic Prophase
  • Signaling by Wnt
  • Signaling by EGFRvIII in Cancer
  • PLCG1 events in ERBB2 signaling
  • Signaling by SCF-KIT
  • DAP12 signaling
  • Regulation of KIT signaling
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • Response to elevated platelet cytosolic Ca2+
  • G alpha (z) signalling events
  • Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
  • Signaling by PDGF
  • Calmodulin induced events
  • DAP12 interactions
  • Regulation of mRNA stability by proteins that bind AU-rich elements
  • Opioid Signalling
  • Diseases associated with visual transduction
  • EGFR interacts with phospholipase C-gamma
  • Signaling by ERBB2
  • Signaling by EGFR
  • Syndecan interactions
  • GPCR downstream signaling
  • Signaling by VEGF
  • Calmodulin induced events
  • Downstream signal transduction
  • WNT5A-dependent internalization of FZD4
  • Signaling by EGFR in Cancer
  • Platelet activation, signaling and aggregation
  • PCP/CE pathway
  • Transmission across Chemical Synapses
  • Trafficking of GluR2-containing AMPA receptors
  • Nuclear Envelope Breakdown
  • HuR stabilizes mRNA
  • DAG and IP3 signaling
  • M Phase
  • VEGFA-VEGFR2 Pathway
  • CaM pathway
  • Inactivation, recovery and regulation of the phototransduction cascade
  • EGFR Transactivation by Gastrin
  • VEGFR2 mediated cell proliferation
  • Downstream signaling of activated FGFR
  • The phototransduction cascade
  • Disinhibition of SNARE formation
  • Innate Immune System
  • Signalling by NGF
  • PLC beta mediated events
  • Regulation of insulin secretion
  • Depolymerisation of the Nuclear Lamina
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • NGF signalling via TRKA from the plasma membrane
  • G-protein mediated events
  • Non-integrin membrane-ECM interactions
  • Signaling by Overexpressed Wild-Type EGFR in Cancer
  • Trafficking of AMPA receptors
  • Cell Cycle, Mitotic
  • Signaling by FGFR
  • beta-catenin independent WNT signaling
  • Acetylcholine regulates insulin secretion
  • Visual phototransduction
  • Ca2+ pathway
  • PLC-gamma1 signalling
  • Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity
  • Phosphatidylserine
  • Vitamin E
  • Ingenol Mebutate
  • Ellagic Acid

Page 7 out of 82 pages